Research Topics
| Mary A VoglerSummaryAffiliation: Cornell University Country: USA Publications
|
Detail Information
Publications
Update: preventing mother-to-child transmission of HIVMary A Vogler
Department of International Medicine and Infectious Diseases, Weill Cornell Medical College of Cornell University and the Center for Special Studies Rogers Unit, New York Presbyterian Hospital, New York, NY 10011, USA
Curr HIV/AIDS Rep 3:59-65. 2006..Primary prevention of HIV in women of childbearing age combined with efforts to prevent mother-to-child transmission of HIV offer the best hope for addressing the burden of HIV in women and children...
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188Mary A Vogler
Department of Medicine, Division of Infectious Diseases, Weill Cornell College of Medicine, New York, NY 10011, USA
J Acquir Immune Defic Syndr 55:473-82. 2010..Pharmacokinetic (PK) interactions between lopinavir/ritonavir (LPV/r) and transdermally delivered ethinyl estradiol (EE) and norelgestromin (NGMN) are unknown...
Complex decisions in managing HIV infection during pregnancyMary A Vogler
Division of Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, Center for Special Studies Rogers Unit, 119 W 24th Street, New York, NY 10011, USA
Curr HIV/AIDS Rep 8:122-31. 2011..Finally, new data have expanded the role of antiviral therapy in allowing safer infant feeding choices for HIV-infected mothers in resource-limited settings...
Pregnancy in a perinatally infected woman: preventing second-generation mother-to-child transmission of HIVMary A Vogler
Weill Medical College of Cornell University, New York, USA
AIDS Read 17:536-40. 2007
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248)Mary A Vogler
New York University Medical Center, New York, NY 10016, USA
J Acquir Immune Defic Syndr 36:576-87. 2004..Approaches to preserve or enhance immune function in HIV-1 infection are needed...
A new heterogeneous liver mass in a patient with well-controlled HIV and HBV infectionMary A Vogler
Division of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA
AIDS Read 16:393-6, 401-2. 2006
Severe headaches and cerebrovascular disease in a young man with perinatally acquired HIV infectionMary A Vogler
Division of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA
AIDS Read 18:354-6, 362-5. 2008
